RNO.AX
Price:
$0.04
Market Cap:
$11.47M
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and ...[Read more]
Industry
Medical - Devices
IPO Date
2007-09-21
Stock Exchange
ASX
Ticker
RNO.AX
According to Rhinomed Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.00. This represents a change of -37.19% compared to the average of -1.59 of the last 4 quarters.
The mean historical PE Ratio of Rhinomed Limited over the last ten years is -3.30. The current -1.00 PE Ratio has changed 2.93% with respect to the historical average. Over the past ten years (40 quarters), RNO.AX's PE Ratio was at its highest in in the December 2023 quarter at 0. The PE Ratio was at its lowest in in the January 2012 quarter at -20.37.
Average
-3.30
Median
-2.74
Minimum
-5.69
Maximum
-1.57
Discovering the peaks and valleys of Rhinomed Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 745.68%
Maximum Annual PE Ratio = -1.57
Minimum Annual Increase = -68.21%
Minimum Annual PE Ratio = -5.69
Year | PE Ratio | Change |
---|---|---|
2023 | -1.83 | -67.81% |
2022 | -5.69 | 24.17% |
2021 | -4.58 | 192.67% |
2020 | -1.57 | -68.21% |
2019 | -4.93 | 5.45% |
2018 | -4.67 | 66.98% |
2017 | -2.80 | 38.91% |
2016 | -2.01 | -24.79% |
2015 | -2.68 | 18.04% |
2014 | -2.27 | 745.68% |
The current PE Ratio of Rhinomed Limited (RNO.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.04
5-year avg
-3.72
10-year avg
-3.30
Rhinomed Limited’s PE Ratio is greater than IDT Australia Limited (-7.15), greater than Botanix Pharmaceuticals Limited (-53.58), greater than Incannex Healthcare Limited (-2.68), less than Zelira Therapeutics Limited (-0.20), greater than Stemcell United Limited (-1.17),
Company | PE Ratio | Market cap |
---|---|---|
-7.15 | $46.49M | |
-53.58 | $863.37M | |
-2.68 | $65.07M | |
-0.20 | $7.15M | |
-1.17 | $3.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhinomed Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rhinomed Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Rhinomed Limited's PE Ratio?
How is the PE Ratio calculated for Rhinomed Limited (RNO.AX)?
What is the highest PE Ratio for Rhinomed Limited (RNO.AX)?
What is the 3-year average PE Ratio for Rhinomed Limited (RNO.AX)?
What is the 5-year average PE Ratio for Rhinomed Limited (RNO.AX)?
How does the current PE Ratio for Rhinomed Limited (RNO.AX) compare to its historical average?